News
FDA approves Ionis, AZ’s Wainua for ATTR polyneuropathy
AstraZeneca and Ionis are planning a US launch next month for Wainua, their treatment for polyneuropathy in life-threatening disease transthyretin-mediated amyloidosis (AT
